EMA Recommends Granting a Marketing Authorisation for Accordpharma Enzalutamide By Ogkologos - December 5, 2025 186 0 Facebook Twitter Google+ Pinterest WhatsApp It is a generic and hybrid of Xtandi, which has been authorised in the EU since 2013 Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Catch-Up HPV Testing May Help Prevent Cervical Cancer in Some Over... September 1, 2023 Man With Cancer Receives $15,000 Check From ‘Secret Santa’ To Help... November 16, 2021 Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Results in Greater EFS and pCR... November 6, 2023 Intensive care nurse describes his experience of female-centred care after breast... February 7, 2023 Load more HOT NEWS Metastasis Likely Caused by Lack of Oxygen in Cancerous Tumors, Study... What Are Drug Shortages and How Can They Impact Care for... Apple Season is Here! Sparing the Hippocampus During PCI Better Preserves Cognitive Function in Patients...
